FDA clears Oleena, first digital therapeutic in oncology

World |  News | 0 Comment | 02 Aug, 2019

Voluntis has announced that it has successfully completed a U.S. Food and Drug Administration (FDA) regulatory review of its Oleena™ software for oncology-related symptoms management ...Read more

GSK completes transaction with Pfizer to form new Consumer Healthcare Joint Venture

World |  News | 0 Comment | 02 Aug, 2019

GlaxoSmithKline plc has announced that it has completed its transaction with Pfizer to combine their consumer healthcare businesses into a world-leading Joint Venture. The Joint Venture br...Read more

FDA new drug approvals up 11% in 2018

World |  Analysis | 0 Comment | 01 Aug, 2019

In 2018 the US Food and Drug Administration (FDA) accepted 137 New Drug Approvals (NDAs) and Biologics License Applications (BLAs) including New Molecular Entities (NMEs) and new formulatio...Read more

Thermo Fisher inks $6M deal with Genome Canada for cancer testing

World |  News | 0 Comment | 01 Aug, 2019

Genome Canada, the Ontario Institute for Cancer Research (OICR) and Thermo Fisher Scientific are collaborating to develop a complete solution of targeted next generation sequencing (NG...Read more

Alizé Pharma 3 raises $75M in Series A

World |  News | 0 Comment | 31 Jul, 2019

Alizé Pharma 3, a company specialized in developing therapeutic peptides for rare endocrine and metabolic diseases has completed a €67 million Series A financing round. The...Read more

Pfizer completes acquisition of Array Biopharma

World |  News | 0 Comment | 31 Jul, 2019

Pfizer Inc.  announced the successful completion of its acquisition of Array BioPharma Inc., advancing breakthrough science for the discovery, development and commercialization of targ...Read more

Exact Sciences inks $2.8B deal with Genomic Health

World |  News | 0 Comment | 31 Jul, 2019

US based Exact Sciences Corp. and Genomic Health, Inc. have announced that the companies have entered into a definitive agreement under which Exact Sciences will combine with Geno...Read more

Dassault Systèmes and FDA extend collaboration to accelerate access to new treatments

World |  News | 0 Comment | 30 Jul, 2019

Dassault Systèmes has announced the five-year extension of its collaboration with the U.S. Food and Drug Administration. The 3DEXPERIENCE platform will be used to develop a new digit...Read more

Mylan and Pfizer to create a new company

World |  News | 0 Comment | 30 Jul, 2019

Mylan and Pfizer Inc. have announced a definitive agreement to combine Mylan with Upjohn, Pfizer’s off-patent branded and generic established medicines business, creating a new global...Read more

Sanofi provides update on Zynquista type 2 diabetes program

World |  News | 0 Comment | 29 Jul, 2019

Sanofi has announced topline results from three Phase 3 trials of ZynquistaTM (sotagliflozin) in adults living with type 2 diabetes from the InSynchrony clinical program. Given the pri...Read more

Hikma, Civica to reduce generic drug shortages in the US

World |  News | 0 Comment | 22 Jul, 2019

Hikma Pharmaceuticals PLC,the multinational generic pharmaceutical company and Civica Rx (Civica, Inc.) have announced a five-year agreement to manufacture and supply Civica’s growing...Read more

US researchers design 3D printed indigestible pill

World |  News | 0 Comment | 29 Jul, 2019

A research team led by Tufts University engineers in the US has developed a 3D printed ingestible pill that samples bacteria found in the gut, known as the microbiome, as it passes through ...Read more

PerkinElmer to expand At Home health services

World |  News | 0 Comment | 26 Jul, 2019

PerkinElmer, Inc. and EverlyWell, Inc. have announced a new collaboration designed to accelerate innovation in and accessibility of consumer-initiated health testing, by addi...Read more

Cipla USA acquires worldwide rights for UTI drug

World |  News | 0 Comment | 25 Jul, 2019

Cipla USA Inc., a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited, announced the acquisition of the prescription drug ZEMDRI (Plazomicin) from A...Read more

Olon expands microbial GMP capabilities in Capua site

World |  News | 0 Comment | 24 Jul, 2019

Olon S.p.A., a world leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier has recently started the construct...Read more

Sanofi signs deal for exclusive US OTC rights to Tamiflu

World |  News | 0 Comment | 24 Jul, 2019

Sanofi signed an agreement with Roche for the exclusive over-the-counter (OTC) rights to Tamiflu® for the prevention and treatment of influenza or flu in the US. Under the terms of...Read more

Medtronic partners with Viz.ai

World |  News | 0 Comment | 24 Jul, 2019

Medtronic plc, a global leader in medical technology, and Viz.ai, the emerging leader in applied artificial intelligence (AI) in stroke care, have partnered to accelerate the adoption of Vi...Read more

NIH publishes largest genomic study on type 2 diabetes in sub-Saharan African populations

World |  News | 0 Comment | 23 Jul, 2019

National Institute of Health researchers have reported the largest genomic study of type 2 diabetes (T2D) in sub-Saharan Africans, with data from more than 5,000 individuals from Nigeria, G...Read more